Karen Bandeen-Roche1,2, Alden L Gross3,4, Ravi Varadhan1,5, Brian Buta2, Michelle C Carlson3,4, Megan Huisingh-Scheetz6, Mara Mcadams-Demarco3, Damani A Piggott2,3, Todd T Brown2, Rani K Hasan2, Rita R Kalyani2, Christopher L Seplaki7, Jeremy D Walston2, Qian-Li Xue1,2,3. 1. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 2. Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland. 3. Department of Epidemiology, Baltimore, Maryland. 4. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 5. Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland. 6. Geriatrics and Palliative Medicine, Department of Medicine, University of Chicago Medicine, Illinois. 7. Department of Public Health Sciences, University of Rochester, New York.
Abstract
INTRODUCTION: "Frailty" has attracted attention for its promise of identifying vulnerable older adults, hence its potential use to better tailor geriatric health care. There remains substantial controversy, however, regarding its nature and ascertainment. Recent years have seen a proliferation of frailty assessment methods. We argue that the development of frailty assessments should be grounded in "validation"-the process of substantiating that a measurement accurately and precisely measures what it intends, identify unresolved measurement issues, and highlight measurement-related considerations for clinical practice. METHODS: Principles for validating frailty measures are elucidated. We follow principles-articulated, for example, by Borsboom-in which a construct must be clearly defined and then analyses undertaken to substantiate that a measurement accurately and precisely measures what it intends. Key elements are content validity, criterion validity, and construct validity, with an emphasis on the latter. RESULTS: We illustrate the principles for a physical frailty phenotype construct. CONCLUSIONS: Unresolved conceptual issues include the roles of intersecting concepts such as cognition, disease severity, and disability in frailty measurement, conceptualization of frailty as a state versus a continuum, and the potential need for dynamic measures and systems concepts in furthering understanding of frailty. Clinical considerations include needs to distinguish interventions designed to address frailty "symptoms" versus underlying physiology, improve "prefrailty" measures intended to screen individuals early in their frailty progression, address feasibility demands, and further visioning followed by rigorous efficacy research to address the landscape of potential uses of frailty assessment in clinical practice.
INTRODUCTION: "Frailty" has attracted attention for its promise of identifying vulnerable older adults, hence its potential use to better tailor geriatric health care. There remains substantial controversy, however, regarding its nature and ascertainment. Recent years have seen a proliferation of frailty assessment methods. We argue that the development of frailty assessments should be grounded in "validation"-the process of substantiating that a measurement accurately and precisely measures what it intends, identify unresolved measurement issues, and highlight measurement-related considerations for clinical practice. METHODS: Principles for validating frailty measures are elucidated. We follow principles-articulated, for example, by Borsboom-in which a construct must be clearly defined and then analyses undertaken to substantiate that a measurement accurately and precisely measures what it intends. Key elements are content validity, criterion validity, and construct validity, with an emphasis on the latter. RESULTS: We illustrate the principles for a physical frailty phenotype construct. CONCLUSIONS: Unresolved conceptual issues include the roles of intersecting concepts such as cognition, disease severity, and disability in frailty measurement, conceptualization of frailty as a state versus a continuum, and the potential need for dynamic measures and systems concepts in furthering understanding of frailty. Clinical considerations include needs to distinguish interventions designed to address frailty "symptoms" versus underlying physiology, improve "prefrailty" measures intended to screen individuals early in their frailty progression, address feasibility demands, and further visioning followed by rigorous efficacy research to address the landscape of potential uses of frailty assessment in clinical practice.
Authors: Jeremy Walston; Evan C Hadley; Luigi Ferrucci; Jack M Guralnik; Anne B Newman; Stephanie A Studenski; William B Ershler; Tamara Harris; Linda P Fried Journal: J Am Geriatr Soc Date: 2006-06 Impact factor: 5.562
Authors: Howard Bergman; Luigi Ferrucci; Jack Guralnik; David B Hogan; Silvia Hummel; Sathya Karunananthan; Christina Wolfson Journal: J Gerontol A Biol Sci Med Sci Date: 2007-07 Impact factor: 6.053
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Divya Thekkethala Winovich; William T Longstreth; Alice M Arnold; Ravi Varadhan; Adina Zeki Al Hazzouri; Mary Cushman; Anne B Newman; Michelle C Odden Journal: Stroke Date: 2017-05-19 Impact factor: 7.914
Authors: David B Hogan; Colleen J Maxwell; Jonathan Afilalo; Rakesh C Arora; Sean M Bagshaw; Jenny Basran; Howard Bergman; Susan E Bronskill; Caitlin A Carter; Elijah Dixon; Brenda Hemmelgarn; Kenneth Madden; Arnold Mitnitski; Darryl Rolfson; Henry T Stelfox; Helen Tam-Tham; Hannah Wunsch Journal: Can Geriatr J Date: 2017-03-31
Authors: Christine E Haugen; Alden Gross; Nadia M Chu; Silas P Norman; Daniel C Brennan; Qian-Li Xue; Jeremy Walston; Dorry L Segev; Mara McAdams-DeMarco Journal: J Gerontol A Biol Sci Med Sci Date: 2021-02-25 Impact factor: 6.053
Authors: Xiaomeng Chen; Omid Shafaat; Yi Liu; Elizabeth A King; Clifford R Weiss; Qian-Li Xue; Jeremy D Walston; Dorry L Segev; Mara A DeMarco Journal: Am J Transplant Date: 2022-05-11 Impact factor: 9.369
Authors: Nadia M Chu; Qian-Li Xue; Mara A McAdams-DeMarco; Michelle C Carlson; Karen Bandeen-Roche; Alden L Gross Journal: Age Ageing Date: 2021-09-11 Impact factor: 12.782
Authors: Mary Ni Lochlainn; Natalie J Cox; Thomas Wilson; Richard P G Hayhoe; Sheena E Ramsay; Antoneta Granic; Masoud Isanejad; Helen C Roberts; Daisy Wilson; Carly Welch; Christopher Hurst; Janice L Atkins; Nuno Mendonça; Katy Horner; Esme R Tuttiett; Yvie Morgan; Phil Heslop; Elizabeth A Williams; Claire J Steves; Carolyn Greig; John Draper; Clare A Corish; Ailsa Welch; Miles D Witham; Avan A Sayer; Sian Robinson Journal: Nutrients Date: 2021-07-09 Impact factor: 5.717